CROCS INC (CROX)

US2270461096 - Common Stock

125.4  +1.89 (+1.53%)

After market: 125.4 0 (0%)

Fundamental Rating

6

Overall CROX gets a fundamental rating of 6 out of 10. We evaluated CROX against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. While CROX has a great profitability rating, there are some minor concerns on its financial health. CROX may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, CROX could be worth investigating further for value investing!.



9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
In the past year CROX had a positive cash flow from operations.
Each year in the past 5 years CROX has been profitable.
In the past 5 years CROX always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 17.07%, CROX belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 54.51%, CROX belongs to the top of the industry, outperforming 98.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 21.96%, CROX belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 10.04%.
The last Return On Invested Capital (21.96%) for CROX is well below the 3 year average (30.08%), which needs to be investigated, but indicates that CROX had better years and this may not be a problem.
Industry RankSector Rank
ROA 17.07%
ROE 54.51%
ROIC 21.96%
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%

1.3 Margins

CROX has a better Profit Margin (20.00%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of CROX has declined.
With an excellent Operating Margin value of 26.40%, CROX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CROX's Operating Margin has improved in the last couple of years.
The Gross Margin of CROX (55.77%) is better than 72.00% of its industry peers.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.4%
PM (TTM) 20%
GM 55.77%
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CROX is creating value.
CROX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
The debt/assets ratio for CROX has been reduced compared to a year ago.

2.2 Solvency

CROX has an Altman-Z score of 3.84. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
CROX has a Altman-Z score of 3.84. This is in the better half of the industry: CROX outperforms 68.00% of its industry peers.
CROX has a debt to FCF ratio of 2.04. This is a good value and a sign of high solvency as CROX would need 2.04 years to pay back of all of its debts.
The Debt to FCF ratio of CROX (2.04) is comparable to the rest of the industry.
CROX has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
CROX has a Debt to Equity ratio of 1.13. This is amonst the worse of the industry: CROX underperforms 82.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 2.04
Altman-Z 3.84
ROIC/WACC2.25
WACC9.75%

2.3 Liquidity

A Current Ratio of 1.30 indicates that CROX should not have too much problems paying its short term obligations.
CROX has a worse Current ratio (1.30) than 76.00% of its industry peers.
A Quick Ratio of 0.75 indicates that CROX may have some problems paying its short term obligations.
CROX's Quick ratio of 0.75 is on the low side compared to the rest of the industry. CROX is outperformed by 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.75

6

3. Growth

3.1 Past

CROX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.27%, which is quite good.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.01% on average per year.
CROX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.46%.
Measured over the past years, CROX shows a very strong growth in Revenue. The Revenue has been growing by 29.49% on average per year.
EPS 1Y (TTM)10.27%
EPS 3Y55.01%
EPS 5YN/A
EPS growth Q2Q-2.64%
Revenue 1Y (TTM)11.46%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Revenue growth Q2Q1.58%

3.2 Future

CROX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.71% yearly.
The Revenue is expected to grow by 7.49% on average over the next years.
EPS Next Y5.59%
EPS Next 2Y7.43%
EPS Next 3Y7.86%
EPS Next 5Y10.71%
Revenue Next Year4.18%
Revenue Next 2Y4.79%
Revenue Next 3Y4.94%
Revenue Next 5Y7.49%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.42, the valuation of CROX can be described as very reasonable.
Based on the Price/Earnings ratio, CROX is valued cheaper than 92.00% of the companies in the same industry.
CROX is valuated cheaply when we compare the Price/Earnings ratio to 24.92, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.87 indicates a reasonable valuation of CROX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 90.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, CROX is valued rather cheaply.
Industry RankSector Rank
PE 10.42
Fwd PE 9.87

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued a bit cheaper than 70.00% of the companies in the same industry.
CROX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CROX is cheaper than 68.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.31
EV/EBITDA 8.17

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CROX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)1.86
PEG (5Y)N/A
EPS Next 2Y7.43%
EPS Next 3Y7.86%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (4/26/2024, 7:00:00 PM)

After market: 125.4 0 (0%)

125.4

+1.89 (+1.53%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 10.42
Fwd PE 9.87
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.07%
ROE 54.51%
ROCE
ROIC
ROICexc
ROICexgc
OM 26.4%
PM (TTM) 20%
GM 55.77%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.3
Quick Ratio 0.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)10.27%
EPS 3Y55.01%
EPS 5Y
EPS growth Q2Q
EPS Next Y5.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.46%
Revenue growth 3Y41.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y